Literature DB >> 29291777

Clear cell hepatocellular carcinoma: origin, metabolic traits and fate of glycogenotic clear and ground glass cells.

Peter Bannasch1, Silvia Ribback2, Qin Su3, Doris Mayer4.   

Abstract

Clear cell hepatocellular carcinoma (CCHCC) has hitherto been considered an uncommon, highly differentiated variant of hepatocellular carcinoma (HCC) with a relatively favorable prognosis. CCHCC is composed of mixtures of clear and/or acidophilic ground glass hepatocytes with excessive glycogen and/or fat and shares histology, clinical features and etiology with common HCCs. Studies in animal models of chemical, hormonal and viral hepatocarcinogenesis and observations in patients with chronic liver diseases prone to develop HCC have shown that the majority of HCCs are preceded by, or associated with, focal or diffuse excessive storage of glycogen (glycogenosis) which later may be replaced by fat (lipidosis/steatosis). In ground glass cells, the glycogenosis is accompanied by proliferation of the smooth endoplasmic reticulum, which is closely related to glycogen particles and frequently harbors the hepatitis B surface antigen (HBsAg). From the findings in animal models a sequence of changes has been established, commencing with preneoplastic glycogenotic liver lesions, often containing ground glass cells, and progressing to glycogen-poor neoplasms via various intermediate stages, including glycogenotic/lipidotic clear cell foci, clear cell hepatocellular adenomas (CCHCA) rich in glycogen and/or fat, and CCHCC. A similar process seems to take place in humans, with clear cells frequently persisting in CCHCC and steatohepatitic HCC, which presumably represent intermediate stages in the development rather than particular variants of HCC. During the progression of the preneoplastic lesions, the clear and ground glass cells transform into cells characteristic of common HCC. The sequential cellular changes are associated with metabolic aberrations, which start with an activation of the insulin signaling cascade resulting in pre-neoplastic hepatic glycogenosis. The molecular and metabolic changes underlying the glycogenosis/lipidosis are apparently responsible for the dramatic metabolic shift from gluconeogenesis to the pentose phosphate pathway and Warburg-type glycolysis, which provide precursors and energy for an ever increasing cell proliferation during progression.
Copyright © 2017 The Editorial Board of Hepatobiliary & Pancreatic Diseases International. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  clear cell hepatocellular carcinoma; glycogenosis; lipidosis; metabolic aberrations; phenotypic heterogeneity; preneoplastic glycogenosis; progression

Mesh:

Substances:

Year:  2017        PMID: 29291777     DOI: 10.1016/S1499-3872(17)60071-7

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  7 in total

Review 1.  Correlation of molecular alterations with pathological features in hepatocellular carcinoma: Literature review and experience of an Italian center.

Authors:  Thais Maloberti; Antonio De Leo; Viviana Sanza; Elisa Gruppioni; Annalisa Altimari; Mattia Riefolo; Michela Visani; Deborah Malvi; Antonia D'Errico; Giovanni Tallini; Francesco Vasuri; Dario de Biase
Journal:  World J Gastroenterol       Date:  2022-07-07       Impact factor: 5.374

Review 2.  Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma.

Authors:  Jiao Feng; Jingjing Li; Liwei Wu; Qiang Yu; Jie Ji; Jianye Wu; Weiqi Dai; Chuanyong Guo
Journal:  J Exp Clin Cancer Res       Date:  2020-07-06

3.  A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis.

Authors:  Yilong Zou; Michael J Palte; Amy A Deik; Haoxin Li; John K Eaton; Wenyu Wang; Yuen-Yi Tseng; Rebecca Deasy; Maria Kost-Alimova; Vlado Dančík; Elizaveta S Leshchiner; Vasanthi S Viswanathan; Sabina Signoretti; Toni K Choueiri; Jesse S Boehm; Bridget K Wagner; John G Doench; Clary B Clish; Paul A Clemons; Stuart L Schreiber
Journal:  Nat Commun       Date:  2019-04-08       Impact factor: 14.919

4.  MYCT1 alters the glycogen shunt by regulating selective translation of RACK1-mediated enzymes.

Authors:  Dong-Xue Ding; Yue Wang; Wei Yan; Wei-Neng Fu
Journal:  iScience       Date:  2022-02-22

5.  Epidemiological and Clinical Characteristics of Five Rare Pathological Subtypes of Hepatocellular Carcinoma.

Authors:  Xiaoyuan Chen; Yiwei Lu; Xiaoli Shi; Guoyong Han; Long Zhang; Chuangye Ni; Jie Zhao; Yun Gao; Xuehao Wang
Journal:  Front Oncol       Date:  2022-04-08       Impact factor: 5.738

6.  CSTF2 Promotes Hepatocarcinogenesis and Hepatocellular Carcinoma Progression via Aerobic Glycolysis.

Authors:  Zhimin Chen; Weijie Hao; Jingzhi Tang; Wei-Qiang Gao; Huiming Xu
Journal:  Front Oncol       Date:  2022-07-08       Impact factor: 5.738

7.  Transcriptomic and Proteomic Analysis of Clear Cell Foci (CCF) in the Human Non-Cirrhotic Liver Identifies Several Differentially Expressed Genes and Proteins with Functions in Cancer Cell Biology and Glycogen Metabolism.

Authors:  Christoph Metzendorf; Katharina Wineberger; Jenny Rausch; Antonio Cigliano; Kristin Peters; Baodong Sun; Daniela Mennerich; Thomas Kietzmann; Diego F Calvisi; Frank Dombrowski; Silvia Ribback
Journal:  Molecules       Date:  2020-09-10       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.